Alx Oncology Holdings 
Biotechnology
Healthcare
ALXO
52.69 M shares
NASDAQ US
traded
03 Feb 2025
listed
no
open
1.41
52 week high
17.56
high
1.41
52 week low
1.21
low
1.22
growth
-91.67 %
previous Close
1.46
P/E ratio
market cap
98.63 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-30.71 M
22.06 %
eps
0.00 %
23.68 %
eps surprise
25.64 %
net profit margin
-3070700000.00 %
0.00 %
operating incoming
-32.57 M
21.57 %
net change in cash
568 K
-61.96 %
cash on hand
16.10 M
3.66 %
cost of revenue
0.00 %
top top